Table 2. Comparisons between Treatment-Response and Non-Response Groups.
Response Group (n = 47) | Non-Response Group (n = 179) | P | |
---|---|---|---|
Demographics | |||
Age (years) | 64.3 ± 7.1 | 65.2 ± 7.5 | 0.509* |
Male:female | 45:2 | 167:12 | 0.375† |
BMI (kg/m2) | 24.37 ± 3.37 | 23.49 ± 3.09 | 0.092* |
PY | 50.04 ± 28.03 | 43.62 ± 29.27 | 0.186* |
GOLD stage (n) | 0.855† | ||
I | 5 | 20 | |
II | 26 | 95 | |
III | 14 | 52 | |
IV | 2 | 12 | |
Initial PFT | |||
FEV1 (%) | 61.6 ± 16.7 | 65.6 ± 19.1 | 0.200* |
FVC (%) | 91.4 ± 16.8 | 92.8 ± 19.0 | 0.632* |
FEV1/FVC | 48.9 ± 11.5 | 50.5 ± 11.8 | 0.393* |
FEF25–75 (%) | 23.6 ± 12.2 | 28.7 ± 16.5 | 0.487* |
TLC (%) | 110.3 ± 23.0 | 107.1 ± 23.8 | 0.425* |
VC (%) | 89.4 ± 17.0 | 93.8 ± 23.3 | 0.229* |
RV (%) | 134.5 ± 58.3 | 120.8 ± 63.3 | 0.194* |
DLCO (%) | 83.9 ± 21.8 | 82.9 ± 22.8 | 0.789* |
6MWD (m) | 455.8 ± 83.4 | 439.3 ± 75.5 | 0.209* |
CT indices | |||
EI | 12.1 ± 9.9 | 15.7 ± 12.4 | 0.066* |
ATI_-856 | 40.0 ± 19.5 | 40.8 ± 20.3 | 0.801* |
ATI_subtraction_1 | 34.5 ± 31.0 | 28.3 ± 14.6 | 0.048* |
ATI_subtraction_2 | 59.1 ± 26.0 | 56.8 ± 26.4 | 0.599* |
ATI_emphysema | 8.3 ± 8.6 | 11.4 ± 11.6 | 0.042* |
ATI_hyperinflated | 20.3 ± 10.2 | 19.6 ± 10.6 | 0.693* |
ATI_normal | 27.7 ± 16.8 | 24.6 ± 17.2 | 0.267* |
Pi10-FWHM (mm) | 4.6 ± 0.4 | 4.5 ± 0.4 | 0.051* |
Pi10-IBHB (mm) | 4.6 ± 0.8 | 4.2 ± 0.8 | 0.002* |
Unless otherwise noted, data are means ± SD. *Independent-sample t test, †Chi-squared test. ATI = air-trapping index, DLCO = diffusing capacity of lung for carbon monoxide, EI = emphysema index, FEF25−75 = forced expiratory flow between 25% and 75% of FVC, FEV1 = forced expiratory volume in 1 second, FVC = forced vital capacity, FWHM = full-width-half-maximum, IBHB = integral-based half-band, PFT = pulmonary function test, Pi10 = square root of airway wall area of theoretical airway with internal perimeter of 10 mm, RV = residual volume, TLC = total lung capacity, VC = vital capacity, 6MWD = 6-minute walk distance